Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

14

Revenue 2017

Lilly

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Lilly's 2013 sales performance.

Lilly

NICE recommends Ibrance and Lynparza, rejects Keytruda and Xospata

NICE recommends Ibrance and Lynparza, rejects Keytruda and Xospata According to NICE, Ibrance now joins two other of its approved drugs – Novartis’ Kisqali (ribociclib) and Lilly’s Verzenio (abemaciclib) - as a treatment option for patients at this stage of the

Lilly expands dermatology portfolio with $1.1bn Dermira deal

Lilly expands dermatology portfolio with $1.1bn Dermira deal Lilly is set to pay Dermira $18.75 per share, a 2.2% premium to Dermira’s last closing price. ... On the back of the acquisition announcement, Dermira’s shares climbed 5.1% to $19.28, above Lilly’s offer price.

New hires at FibroGen, Saniona and Turbine

New hires at FibroGen, Saniona and Turbine Eli Lilly and president of Lilly Diabetes and USA. ... Conterno joined Eli Lilly in 1992, and went on to spend two decades working at the company, both in the US and internationally.

AstraZeneca’s heart failure drug Farxiga scores FDA priority review

AstraZeneca’s heart failure drug Farxiga scores FDA priority review AZ is hoping to make some gains on SGLT2 inhibitor market leader Jardiance (empagliflozin) from Eli Lilly and Boehringer Ingelheim. ... Boehringer and Lilly are also testing Jardiance in both HFrEF and EFpEF with two trials – EMPEROR-Reduced and EMPEROR

Driving the innovation engine

Driving the innovation engine Eli Lilly is an example of one of the major players to explore this area. ... According to Lilly, over 360 universities, research institutes and small biotechs, representing 34 countries, are now affiliated with the programme.

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Novasecta

We are a specialist strategy consulting firm for pharmaceutical and biotech companies. We help our clients to achieve significant performance...

Latest intelligence

How do companies prepare for reimbursement?
Valid Insight explore how to optimise your market access strategy during new product development, how to address payer concerns and prepare for reimbursement....
EHR clinical trials
Integrating electronic health records into clinical trials
How organisations are working to realise the research potential of EHRs...
Mike Elliott Gilead
Keeping up the fight against HIV and using the lessons to tackle other threats
Danny Buckland interviews Gilead’s Mike Elliott...

Infographics